Ambev price target lowered to $2.85 from $2.90 at UBS
Downgrade with modest price weakness; downside risk persists.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Downgrade with modest price weakness; downside risk persists.
What happened, with direct paths to the underlying reporting
UBS lowers Ambev target to $2.85 from $2.90; posted price: $2.92. Price change since signal: -2.57%.
Target: $2.85
Posted price: $2.92
Analyst firm: UBS
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.